NVO logo

Novo Nordisk A/S (NVO) Net income

annual net income:

$14.65B+$2.50B(+20.62%)
December 31, 2024

Summary

  • As of today (August 22, 2025), NVO annual net profit is $14.65 billion, with the most recent change of +$2.50 billion (+20.62%) on December 31, 2024.
  • During the last 3 years, NVO annual net income has risen by +$7.06 billion (+92.95%).
  • NVO annual net income is now at all-time high.

Performance

NVO Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

quarterly net income:

$4.03B-$67.16M(-1.64%)
June 1, 2025

Summary

  • As of today (August 22, 2025), NVO quarterly net profit is $4.03 billion, with the most recent change of -$67.16 million (-1.64%) on June 1, 2025.
  • Over the past year, NVO quarterly net income has increased by +$1.14 billion (+39.24%).
  • NVO quarterly net income is now -1.64% below its all-time high of $4.10 billion, reached on March 31, 2025.

Performance

NVO quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

TTM net income:

$16.18B+$1.14B(+7.55%)
June 1, 2025

Summary

  • As of today (August 22, 2025), NVO TTM net profit is $16.18 billion, with the most recent change of +$1.14 billion (+7.55%) on June 1, 2025.
  • Over the past year, NVO TTM net income has increased by +$3.14 billion (+24.10%).
  • NVO TTM net income is now at all-time high.

Performance

NVO TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

NVO Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+20.6%+39.2%+24.1%
3 y3 years+93.0%+111.5%+111.7%
5 y5 years+150.8%+156.8%+163.8%

NVO Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+93.0%-1.6%+116.2%at high+111.7%
5 y5-yearat high+150.8%-1.6%+169.9%at high+163.8%
alltimeall timeat high>+9999.0%-1.6%>+9999.0%at high>+9999.0%

NVO Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
$4.03B(-1.6%)
$16.18B(+7.5%)
Mar 2025
-
$4.10B(+1.5%)
$15.05B(+2.7%)
Dec 2024
$14.65B(+20.6%)
$4.04B(+0.4%)
$14.65B(+6.3%)
Sep 2024
-
$4.02B(+38.9%)
$13.78B(+5.7%)
Jun 2024
-
$2.89B(-21.8%)
$13.04B(+0.4%)
Mar 2024
-
$3.70B(+16.8%)
$12.98B(+6.9%)
Dec 2023
$12.14B(+54.8%)
$3.17B(-3.5%)
$12.14B(+12.0%)
Sep 2023
-
$3.28B(+15.6%)
$10.84B(+14.0%)
Jun 2023
-
$2.84B(-0.6%)
$9.51B(+10.9%)
Mar 2023
-
$2.86B(+53.2%)
$8.57B(+9.1%)
Dec 2022
$7.84B(+3.3%)
$1.86B(-4.4%)
$7.86B(+2.5%)
Sep 2022
-
$1.95B(+2.3%)
$7.67B(+0.4%)
Jun 2022
-
$1.91B(-11.1%)
$7.64B(-0.8%)
Mar 2022
-
$2.14B(+28.0%)
$7.70B(+1.3%)
Dec 2021
$7.59B(+17.8%)
$1.67B(-12.9%)
$7.60B(+2.4%)
Sep 2021
-
$1.92B(-2.3%)
$7.42B(+4.3%)
Jun 2021
-
$1.97B(-3.9%)
$7.12B(+5.9%)
Mar 2021
-
$2.04B(+37.0%)
$6.72B(+4.5%)
Dec 2020
$6.44B(+10.4%)
$1.49B(-7.7%)
$6.43B(+3.2%)
Sep 2020
-
$1.62B(+3.0%)
$6.23B(+1.6%)
Jun 2020
-
$1.57B(-10.6%)
$6.13B(+2.1%)
Mar 2020
-
$1.75B(+35.8%)
$6.01B(+2.8%)
Dec 2019
$5.84B(-4.5%)
$1.29B(-14.9%)
$5.84B(-0.1%)
Sep 2019
-
$1.52B(+5.2%)
$5.85B(+1.9%)
Jun 2019
-
$1.44B(-9.1%)
$5.74B(-3.5%)
Mar 2019
-
$1.59B(+22.3%)
$5.95B(-3.0%)
Dec 2018
$6.11B(+5.7%)
$1.30B(-7.8%)
$6.14B(-0.1%)
Sep 2018
-
$1.41B(-14.7%)
$6.14B(-2.1%)
Jun 2018
-
$1.65B(-6.8%)
$6.28B(+3.0%)
Mar 2018
-
$1.77B(+35.9%)
$6.10B(+5.5%)
Dec 2017
$5.78B(+2.6%)
$1.31B(-15.4%)
$5.78B(+0.8%)
Sep 2017
-
$1.54B(+4.7%)
$5.73B(+1.3%)
Jun 2017
-
$1.47B(+1.2%)
$5.66B(-0.7%)
Mar 2017
-
$1.46B(+15.5%)
$5.70B(+1.0%)
Dec 2016
$5.63B(+8.7%)
$1.26B(-14.3%)
$5.64B(+0.9%)
Sep 2016
-
$1.47B(-2.8%)
$5.59B(+4.1%)
Jun 2016
-
$1.51B(+8.3%)
$5.37B(+5.4%)
Mar 2016
-
$1.40B(+15.3%)
$5.09B(-1.8%)
Dec 2015
$5.18B(+10.0%)
$1.21B(-3.0%)
$5.19B(+2.3%)
Sep 2015
-
$1.25B(+1.0%)
$5.07B(+1.9%)
Jun 2015
-
$1.24B(-17.0%)
$4.98B(-1.0%)
Mar 2015
-
$1.49B(+36.0%)
$5.03B(+6.4%)
Dec 2014
$4.71B(+5.1%)
$1.10B(-5.2%)
$4.72B(-0.2%)
Sep 2014
-
$1.16B(-10.1%)
$4.73B(+0.4%)
Jun 2014
-
$1.29B(+8.4%)
$4.71B(+2.3%)
Mar 2014
-
$1.19B(+7.3%)
$4.61B(+2.8%)
Dec 2013
$4.48B(+21.2%)
$1.10B(-3.0%)
$4.48B(+2.4%)
Sep 2013
-
$1.14B(-3.4%)
$4.38B(+4.5%)
Jun 2013
-
$1.18B(+11.4%)
$4.19B(+6.6%)
Mar 2013
-
$1.06B(+5.8%)
$3.93B(+6.4%)
Dec 2012
$3.70B(+15.9%)
$1.00B(+5.2%)
$3.70B(+4.3%)
Sep 2012
-
$951.56M(+3.2%)
$3.54B(+4.6%)
Jun 2012
-
$921.71M(+12.1%)
$3.39B(+3.8%)
Mar 2012
-
$822.31M(-3.2%)
$3.26B(+2.3%)
Dec 2011
$3.19B(+24.7%)
$849.10M(+6.7%)
$3.19B(+4.3%)
Sep 2011
-
$795.85M(-0.2%)
$3.06B(+6.0%)
Jun 2011
-
$797.71M(+6.7%)
$2.89B(+7.1%)
Mar 2011
-
$747.61M(+4.1%)
$2.69B(+5.1%)
Dec 2010
$2.56B(+27.3%)
$718.13M(+15.5%)
$2.56B(+11.2%)
Sep 2010
-
$621.89M(+2.8%)
$2.31B(+4.2%)
Jun 2010
-
$605.23M(-1.9%)
$2.21B(+2.7%)
Mar 2010
-
$617.19M(+33.9%)
$2.15B(+7.2%)
Dec 2009
$2.01B(+6.2%)
$461.02M(-12.9%)
$2.01B(+2.5%)
Sep 2009
-
$529.15M(-3.3%)
$1.96B(-0.4%)
Jun 2009
-
$546.93M(+16.0%)
$1.97B(+1.5%)
Mar 2009
-
$471.65M(+14.5%)
$1.94B(+1.8%)
Dec 2008
$1.89B(+20.9%)
$411.80M(-23.2%)
$1.90B(+13.2%)
Sep 2008
-
$536.13M(+3.6%)
$1.68B(+8.6%)
Jun 2008
-
$517.43M(+18.1%)
$1.55B(-8.5%)
Mar 2008
-
$437.98M(+130.9%)
$1.69B(+8.8%)
Dec 2007
$1.57B(+44.2%)
$189.71M(-52.9%)
$1.55B(-6.5%)
Sep 2007
-
$403.15M(-39.0%)
$1.66B(+6.4%)
Jun 2007
-
$661.10M(+120.0%)
$1.56B(+30.7%)
Mar 2007
-
$300.49M(+0.8%)
$1.20B(+9.7%)
Dec 2006
$1.09B(+11.1%)
$298.02M(-1.6%)
$1.09B(+10.9%)
Sep 2006
-
$303.01M(+3.1%)
$982.78M(+1.7%)
Jun 2006
-
$294.01M(+50.6%)
$966.21M(+1.0%)
Mar 2006
-
$195.20M(+2.4%)
$956.69M(-2.2%)
Dec 2005
$977.42M(+16.8%)
$190.56M(-33.5%)
$978.45M(-6.2%)
Sep 2005
-
$286.44M(+0.7%)
$1.04B(+8.9%)
Jun 2005
-
$284.48M(+31.1%)
$957.82M(+8.9%)
Mar 2005
-
$216.96M(-14.9%)
$879.28M(+4.8%)
Dec 2004
$837.09M
$254.88M(+26.5%)
$838.95M(+4.8%)
DateAnnualQuarterlyTTM
Sep 2004
-
$201.49M(-2.2%)
$800.33M(+3.9%)
Jun 2004
-
$205.94M(+16.6%)
$770.06M(+1.2%)
Mar 2004
-
$176.64M(-18.3%)
$760.77M(+2.6%)
Dec 2003
$738.86M(+42.2%)
$216.25M(+26.3%)
$741.71M(+8.6%)
Sep 2003
-
$171.22M(-12.9%)
$683.26M(+6.0%)
Jun 2003
-
$196.65M(+24.8%)
$644.75M(+10.5%)
Mar 2003
-
$157.58M(-0.1%)
$583.51M(+11.5%)
Dec 2002
$519.65M(+12.0%)
$157.80M(+18.9%)
$523.15M(+7.5%)
Sep 2002
-
$132.71M(-2.0%)
$486.63M(+4.1%)
Jun 2002
-
$135.42M(+39.3%)
$467.35M(+7.3%)
Mar 2002
-
$97.22M(-19.8%)
$435.68M(-6.2%)
Dec 2001
$463.96M(+21.7%)
$121.28M(+6.9%)
$464.60M(+11.8%)
Sep 2001
-
$113.43M(+9.3%)
$415.40M(+37.6%)
Jun 2001
-
$103.75M(-17.8%)
$301.97M(+52.3%)
Mar 2001
-
$126.14M(+75.0%)
$198.22M(+21.7%)
Dec 2000
$381.39M(+10.5%)
$72.08M(-20.7%)
$162.92M(-11.3%)
Mar 2000
-
$90.84M(-2.2%)
$183.67M(-47.9%)
Dec 1999
$345.04M(-3.8%)
-
-
Jun 1999
-
$92.84M(+25.0%)
$352.62M(-4.0%)
Mar 1999
-
$74.27M(-22.3%)
$367.29M(-2.7%)
Dec 1998
$358.74M(+7.1%)
$95.58M(+6.3%)
$377.42M(-0.4%)
Sep 1998
-
$89.94M(-16.3%)
$378.85M(+0.8%)
Jun 1998
-
$107.51M(+27.4%)
$375.76M(+6.5%)
Mar 1998
-
$84.39M(-13.0%)
$352.69M(+6.5%)
Dec 1997
$334.88M(+8.1%)
$97.01M(+11.7%)
$331.07M(+5.9%)
Sep 1997
-
$86.84M(+2.8%)
$312.69M(+1.9%)
Jun 1997
-
$84.44M(+34.5%)
$306.98M(+1.8%)
Mar 1997
-
$62.77M(-20.2%)
$301.47M(-2.4%)
Dec 1996
$309.78M(+11.0%)
$78.64M(-3.1%)
$308.91M(+5.2%)
Sep 1996
-
$81.13M(+2.8%)
$293.59M(+0.6%)
Jun 1996
-
$78.93M(+12.4%)
$291.94M(-1.0%)
Mar 1996
-
$70.22M(+10.9%)
$294.77M(+6.4%)
Dec 1995
$279.09M(+23.8%)
$63.32M(-20.3%)
$276.96M(-6.3%)
Sep 1995
-
$79.48M(-2.8%)
$295.53M(+6.2%)
Jun 1995
-
$81.76M(+56.0%)
$278.26M(+16.1%)
Mar 1995
-
$52.41M(-36.0%)
$239.60M(+5.5%)
Dec 1994
$225.34M(+2.4%)
$81.90M(+31.7%)
$227.07M(+9.0%)
Sep 1994
-
$62.20M(+44.3%)
$208.38M(+0.8%)
Jun 1994
-
$43.10M(+8.1%)
$206.67M(-2.0%)
Mar 1994
-
$39.87M(-36.9%)
$210.89M(-2.8%)
Dec 1993
$220.01M(+4.0%)
$63.21M(+4.5%)
$217.00M(-1.3%)
Sep 1993
-
$60.49M(+27.8%)
$219.83M(+10.0%)
Jun 1993
-
$47.32M(+2.9%)
$199.79M(-3.1%)
Mar 1993
-
$45.98M(-30.4%)
$206.28M(-2.6%)
Dec 1992
$211.61M(+45.9%)
$66.04M(+63.3%)
$211.84M(+19.3%)
Sep 1992
-
$40.45M(-24.8%)
$177.55M(-0.0%)
Jun 1992
-
$53.81M(+4.4%)
$177.56M(+12.8%)
Mar 1992
-
$51.54M(+62.3%)
$157.35M(+7.7%)
Dec 1991
$145.08M(+18.0%)
$31.75M(-21.5%)
$146.09M(+2.4%)
Sep 1991
-
$40.46M(+20.4%)
$142.73M(+6.5%)
Jun 1991
-
$33.60M(-16.6%)
$134.02M(+1.6%)
Mar 1991
-
$40.28M(+41.9%)
$131.93M(+7.6%)
Dec 1990
$122.93M(+20.3%)
$28.39M(-10.6%)
$122.64M(+8.7%)
Sep 1990
-
$31.75M(+0.8%)
$112.81M(+4.8%)
Jun 1990
-
$31.51M(+1.7%)
$107.65M(+11.8%)
Mar 1990
-
$30.99M(+67.0%)
$96.27M(-5.9%)
Dec 1989
$102.20M(+7.9%)
$18.56M(-30.2%)
$102.30M(+0.9%)
Sep 1989
-
$26.59M(+32.1%)
$101.36M(+7.1%)
Jun 1989
-
$20.13M(-45.6%)
$94.65M(-11.9%)
Mar 1989
-
$37.02M(+110.0%)
$107.46M(+14.7%)
Dec 1988
$94.71M(+34.1%)
$17.63M(-11.3%)
$93.68M(-5.1%)
Sep 1988
-
$19.87M(-39.7%)
$98.71M(+2.9%)
Jun 1988
-
$32.94M(+41.7%)
$95.90M(+24.1%)
Mar 1988
-
$23.24M(+2.6%)
$77.27M(+7.7%)
Dec 1987
$70.62M(+10.2%)
$22.66M(+32.8%)
$71.77M(+7.1%)
Sep 1987
-
$17.06M(+19.2%)
$67.00M(+0.5%)
Jun 1987
-
$14.31M(-19.3%)
$66.70M(-2.5%)
Mar 1987
-
$17.74M(-0.9%)
$68.42M(+5.6%)
Dec 1986
$64.09M(+12.1%)
$17.89M(+6.8%)
$64.82M(+8.7%)
Sep 1986
-
$16.76M(+4.5%)
$59.62M(+3.6%)
Jun 1986
-
$16.03M(+13.4%)
$57.52M(+3.3%)
Mar 1986
-
$14.13M(+11.4%)
$55.70M(-2.3%)
Dec 1985
$57.20M(-13.6%)
$12.69M(-13.5%)
$57.03M(-7.0%)
Sep 1985
-
$14.67M(+3.2%)
$61.31M(-3.8%)
Jun 1985
-
$14.21M(-8.1%)
$63.76M(-2.9%)
Mar 1985
-
$15.46M(-8.9%)
$65.68M(-1.2%)
Dec 1984
$66.23M(-11.7%)
$16.97M(-0.8%)
$66.51M(+34.3%)
Sep 1984
-
$17.11M(+6.1%)
$49.54M(+52.8%)
Jun 1984
-
$16.14M(-1.0%)
$32.43M(+99.0%)
Mar 1984
-
$16.29M
$16.29M
Dec 1983
$74.99M(+13.2%)
-
-
Dec 1982
$66.27M(+38.5%)
-
-
Dec 1981
$47.85M(+53.1%)
-
-
Dec 1980
$31.25M
-
-

FAQ

  • What is Novo Nordisk A/S annual net profit?
  • What is the all time high annual net income for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual net income year-on-year change?
  • What is Novo Nordisk A/S quarterly net profit?
  • What is the all time high quarterly net income for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly net income year-on-year change?
  • What is Novo Nordisk A/S TTM net profit?
  • What is the all time high TTM net income for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM net income year-on-year change?

What is Novo Nordisk A/S annual net profit?

The current annual net income of NVO is $14.65B

What is the all time high annual net income for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual net profit is $14.65B

What is Novo Nordisk A/S annual net income year-on-year change?

Over the past year, NVO annual net profit has changed by +$2.50B (+20.62%)

What is Novo Nordisk A/S quarterly net profit?

The current quarterly net income of NVO is $4.03B

What is the all time high quarterly net income for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly net profit is $4.10B

What is Novo Nordisk A/S quarterly net income year-on-year change?

Over the past year, NVO quarterly net profit has changed by +$1.14B (+39.24%)

What is Novo Nordisk A/S TTM net profit?

The current TTM net income of NVO is $16.18B

What is the all time high TTM net income for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM net profit is $16.18B

What is Novo Nordisk A/S TTM net income year-on-year change?

Over the past year, NVO TTM net profit has changed by +$3.14B (+24.10%)
On this page